pharmaceutical investing Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update